Target-tracking deliveries on an Elekta linac: a feasibility study.
A target-tracking, intensity-modulated delivery on an Elekta MLCi system was assessed by film measurement with a simulated target-motion trajectory. A toroidally shaped idealized target surrounding an organ at risk necessitating multiple field segments to irradiate the target and spare the organ at...
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Journal article |
| Kieli: | English |
| Julkaistu: |
2009
|
| _version_ | 1826258298327793664 |
|---|---|
| author | McQuaid, D Partridge, M Symonds-Tayler, JR Evans, P Webb, S |
| author_facet | McQuaid, D Partridge, M Symonds-Tayler, JR Evans, P Webb, S |
| author_sort | McQuaid, D |
| collection | OXFORD |
| description | A target-tracking, intensity-modulated delivery on an Elekta MLCi system was assessed by film measurement with a simulated target-motion trajectory. A toroidally shaped idealized target surrounding an organ at risk necessitating multiple field segments to irradiate the target and spare the organ at risk was defined in a solid-water phantom. The phantom was programmed to move following a reproducible 2D elliptical trajectory in the beam's-eye view with a period of 10 s. Static and target-tracking treatments were planned for delivery on a standard Elekta Precise series linac with integrated MLCi system. Dose was delivered in three ways: (i) a static treatment to a static phantom, (ii) a static treatment to a moving phantom and (iii) a target-tracking treatment to a moving phantom. The dose delivered was assessed by film measurement on the central plane through the target and organ at risk. The target dose blurring was quantified by the standard deviation of the dose to the target which was evaluated as 2.8% for the static treatment to the static phantom, 7.2% for the static treatment to the moving phantom and 2.6% for the tracking treatment to the moving phantom. The mean organ-at-risk dose was 38.2%, 54.0% and 38.2% of the prescription dose for each delivery case. We have therefore shown that the linac is capable of delivering target-tracking fields with MLCs for the target trajectories tested. |
| first_indexed | 2024-03-06T18:31:46Z |
| format | Journal article |
| id | oxford-uuid:09e3e372-56af-4828-afa9-278493fe47e7 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T18:31:46Z |
| publishDate | 2009 |
| record_format | dspace |
| spelling | oxford-uuid:09e3e372-56af-4828-afa9-278493fe47e72022-03-26T09:20:50ZTarget-tracking deliveries on an Elekta linac: a feasibility study.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:09e3e372-56af-4828-afa9-278493fe47e7EnglishSymplectic Elements at Oxford2009McQuaid, DPartridge, MSymonds-Tayler, JREvans, PWebb, SA target-tracking, intensity-modulated delivery on an Elekta MLCi system was assessed by film measurement with a simulated target-motion trajectory. A toroidally shaped idealized target surrounding an organ at risk necessitating multiple field segments to irradiate the target and spare the organ at risk was defined in a solid-water phantom. The phantom was programmed to move following a reproducible 2D elliptical trajectory in the beam's-eye view with a period of 10 s. Static and target-tracking treatments were planned for delivery on a standard Elekta Precise series linac with integrated MLCi system. Dose was delivered in three ways: (i) a static treatment to a static phantom, (ii) a static treatment to a moving phantom and (iii) a target-tracking treatment to a moving phantom. The dose delivered was assessed by film measurement on the central plane through the target and organ at risk. The target dose blurring was quantified by the standard deviation of the dose to the target which was evaluated as 2.8% for the static treatment to the static phantom, 7.2% for the static treatment to the moving phantom and 2.6% for the tracking treatment to the moving phantom. The mean organ-at-risk dose was 38.2%, 54.0% and 38.2% of the prescription dose for each delivery case. We have therefore shown that the linac is capable of delivering target-tracking fields with MLCs for the target trajectories tested. |
| spellingShingle | McQuaid, D Partridge, M Symonds-Tayler, JR Evans, P Webb, S Target-tracking deliveries on an Elekta linac: a feasibility study. |
| title | Target-tracking deliveries on an Elekta linac: a feasibility study. |
| title_full | Target-tracking deliveries on an Elekta linac: a feasibility study. |
| title_fullStr | Target-tracking deliveries on an Elekta linac: a feasibility study. |
| title_full_unstemmed | Target-tracking deliveries on an Elekta linac: a feasibility study. |
| title_short | Target-tracking deliveries on an Elekta linac: a feasibility study. |
| title_sort | target tracking deliveries on an elekta linac a feasibility study |
| work_keys_str_mv | AT mcquaidd targettrackingdeliveriesonanelektalinacafeasibilitystudy AT partridgem targettrackingdeliveriesonanelektalinacafeasibilitystudy AT symondstaylerjr targettrackingdeliveriesonanelektalinacafeasibilitystudy AT evansp targettrackingdeliveriesonanelektalinacafeasibilitystudy AT webbs targettrackingdeliveriesonanelektalinacafeasibilitystudy |